LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Benitec Biopharma (NASDAQ: BNTC)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ BNTC Benitec Biopharma
Mukadam Sophie / officer: Chief Operating Officer
11/18/2025
Buy
$13.53
500,000
$6.765M
500,000
NASDAQ BNTC Benitec Biopharma
Banks Jerel A. / director, officer: Chief Executive Officer
11/18/2025
Buy
$13.53
450,000
$6.089M
450,000
NASDAQ BNTC Benitec Biopharma
Boston Megan / director, officer: Chief Financial Officer
11/18/2025
Buy
$13.53
200,000
$2.706M
200,000
NASDAQ BNTC Benitec Biopharma
SUVRETTA CAPITAL MANAGEMENT, LLC / director, 10 percent owner:
11/07/2025
Buy
$13.50
730,370
$9.860M
9.54M
NASDAQ BNTC Benitec Biopharma
SUVRETTA CAPITAL MANAGEMENT, LLC / director, 10 percent owner:
11/07/2025
Buy
$13.50
751,111
$10.140M
1.82M
NASDAQ BNTC Benitec Biopharma
Mates Sharon / director
11/05/2025
Buy
$15.78
28,517
$450K
28,517